RZM

(2R,3R,4R,5R)-4-hydroxy-2,5-bis(hydroxymethyl)pyrrolidin-3-yl alpha-D-glucopyranoside

Created:	2014-07-24
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where RZM is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	45
Chiral Atom Count	9
Bond Count	46
Aromatic Bond Count	0

2D diagram of RZM

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R,3R,4R,5R)-4-hydroxy-2,5-bis(hydroxymethyl)pyrrolidin-3-yl alpha-D-glucopyranoside
Synonyms	(2R,3R,4R,5R)-4-hydroxy-2,5-bis(hydroxymethyl)pyrrolidin-3-yl alpha-D-glucoside; (2R,3R,4R,5R)-4-hydroxy-2,5-bis(hydroxymethyl)pyrrolidin-3-yl D-glucoside; (2R,3R,4R,5R)-4-hydroxy-2,5-bis(hydroxymethyl)pyrrolidin-3-yl glucoside
Systematic Name (OpenEye OEToolkits)	(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-2,5-bis(hydroxymethyl)-4-oxidanyl-pyrrolidin-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-tr iol
Formula	C₁₂ H₂₃ N O₉
Molecular Weight	325.312
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O(C1C(O)C(NC1CO)CO)C2OC(C(O)C(O)C2O)CO
SMILES	CACTVS	3.385	OC[CH]1N[CH](CO)[CH](O[CH]2O[CH](CO)[CH](O)[CH](O)[CH]2O)[CH]1O
SMILES	OpenEye OEToolkits	1.9.2	C(C1C(C(C(N1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O
Canonical SMILES	CACTVS	3.385	OC[C@H]1N[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.9.2	C([C@@H]1[C@H]([C@@H]([C@H](N1)CO)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O
InChI	InChI	1.03	InChI=1S/C12H23NO9/c14-1-4-7(17)11(5(2-15)13-4)22-12-10(20)9(19)8(18)6(3-16)21-12/h4-20H,1-3H2/t4-,5-,6-,7-,8-,9+,10-,11-,12-/m1/s1
InChIKey	InChI	1.03	AZDBETUGBOOBRU-BBFNFCGLSA-N

Related Resource References

Resource Name	Reference
PubChem	10947328
ChEMBL	CHEMBL3786370

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.